Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Boston Scientific’s proposed $4.2 billion acquisition of medical equipment and pharmaceutical supplier BTG plc would violate federal antitrust law. According to the complaint, which was first announced in August 2019, as proposed, Boston Scientific’s acquisition of BTG would have […]